Abstract: Methods and devices are provided, where the device includes a plurality of wireless communication units. The wireless communication device also includes a first interface unit configured to synchronize a data signal received from one of the plurality of wireless communication units with a first clock corresponding to the one of the plurality of wireless communication units, and configured to output the synchronized data signal to a second interface unit. The second interface unit is configured to receive the synchronized data signal using a second clock having a shorter period than the first clock, count a number of periods of the second clock during at least one period of the first clock, and determine an output port for the synchronized data signal based on a result of the counting. The wireless communication device further includes a plurality of processors for processing data signals.

Abstract: Disclosed is provided to overcome problems of conventional methods using each of a solid discharge nozzle and a screw conveyer. According to one exemplary embodiment of the present invention, a fluidized bed system is provided to circulate solids using pressure and density difference. More particularly, a fluidized solid circulation system using pressure and density difference is characterized by comprising: a first fluidized bed reactor; a second fluidized bed reactor; a first cyclone; a second cyclone; a first pressure control valve; a second pressure control valve; a lower loop seal; an upper loop seal; and a control part, thereby circulating the solids between the first fluidized bed reactor and the second fluidized bed reactor.

Abstract: The invention provides mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4) inhibitors, and pharmaceutically acceptable salts, hydrides and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition, and detecting a resultant diminution of tumor cell growth, cancer or metastasis.

Abstract: The invention provides mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4) inhibitors, and pharmaceutically acceptable salts, hydrides and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition, and detecting a resultant diminution of tumor cell growth, cancer or metastasis.

Abstract: Methods and devices are provided, where the device includes a plurality of wireless communication units. The wireless communication device also includes a first interface unit configured to synchronize a data signal received from one of the plurality of wireless communication units with a first clock corresponding to the one of the plurality of wireless communication units, and configured to output the synchronized data signal to a second interface unit. The second interface unit is configured to receive the synchronized data signal using a second clock having a shorter period than the first clock, count a number of periods of the second clock during at least one period of the first clock, and determine an output port for the synchronized data signal based on a result of the counting. The wireless communication device further includes a plurality of processors for processing data signals.

Abstract: The present invention relates to a fluidized bed reactor capable of varying flow velocity, in which the flow velocity in the fluidized bed reactor varies to maintain the smooth transportation of solid particles while increasing the concentration of a gaseous reactant in relation to the solid particles. The fluidized bed reactor comprises: a lower high-speed unit into which solid particles and fluid particles are introduced; a middle low-speed unit continuously connected to an upper portion of the lower high-speed unit so that the flow velocity therein becomes lower than that in the lower high-speed unit; and an upper high-speed unit continuously connected to an upper portion of the middle low-speed unit so that the flow velocity therein becomes higher than that in the middle low-speed unit.

Abstract: Disclosed is a dry carbon dioxide capturing device which can improve sorption efficiency by supplying sorbent for absorbing carbon dioxide or exhaust gas containing carbon dioxide to a recovery reactor in multistages at various heights. The dry carbon dioxide (CO2) capturing device with multistage supply structure comprises a recovery reactor 102 to recover CO2 by contacting a solid sorbent with exhaust gas; a recovery cyclone 110 connected to the recovery reactor 102 to discharge a gas while separating the CO2-captured solid sorbent only; a regenerator 114 connected to the recovery cyclone 110 to receive the CO2-captured solid sorbent and separate CO2 captured in the solid sorbent; and a pre-treatment reactor 122 connected to the regenerator 114 for cooling the solid sorbent free from CO2, wherein at least one of the exhaust gas supply line and the sorbent supply line has two or more arranged according to the height of the recovery reactor 102.

Abstract: Disclosed is a dry CO2 capturing device using multi sorbents so as to maintain the sorption rate for exhaust gas containing CO2. The dry carbon dioxide (CO2) capturing device comprises at least two dry carbon dioxide (CO2) capturing parts comprising: a first and second recovery reactors 104 and 105 to recover CO2 by contacting a solid sorbent with exhaust gas; a first and second recovery cyclones 106 and 122 connected to the recovery reactors; a first and second regenerators 110 and 126 connected to the recovery cyclones; and a first and second pre-treatment reactors 116 and 132 connected to the regenerators through sorbent supply lines.

Abstract: Disclosed is a dry CO2 capturing device with improved energy efficiency, which utilizes a difference in temperature between a regeneration operation of isolating CO2 from an sorbent containing CO2 absorbed therein and a pre-treatment operation of allowing H2O to be adsorbed to CO2. The dry carbon dioxide (CO2) capturing device, includes a recovery reactor for recovering CO2, a recovery cyclone for discharging a gas while separating the CO2-captured solid sorbent only, a regenerator for receiving the CO2-captured solid sorbent and separating CO2 captured in the solid sorbent, and a pre-treatment reactor for cooling the solid sorbent free from CO2, wherein a first heat exchanger is provided between the recovery cyclone and the regenerator to pass the CO2-captured solid sorbent therethrough, and a second heat exchanger is provided between the pre-treatment reactor and the regenerator to pass the solid sorbent free from CO2 therethrough.

Abstract: This application discloses novel pyrimidinyl pyridone derivatives according to formula I, wherein A, R1, R2, R3, and m are defined as described herein, which inhibit JNK. The compounds disclosed herein are useful to modulate the activity of JNK and treat diseases associated with excessive JNK activity. The compounds are useful to treat autoimmune, inflammatory, metabolic, and neurological diseases as well as cancer. Also disclosed are compositions comprising the compound of formula I and methods of treatment comprising administering a therapeutically effective amount of the compound of formula I to a subject in need thereof.

Abstract: The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, wherein the variables Q and R are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.

Abstract: This application discloses novel pyrimidinyl pyridone derivatives according to formula I, wherein A, R1, R2, R3, and m are defined as described herein, which inhibit JNK. The compounds disclosed herein are useful to modulate the activity of JNK and treat diseases associated with excessive JNK activity. The compounds are useful to treat autoimmune, inflammatory, metabolic, and neurological diseases as well as cancer. Also disclosed are compositions comprising the compound of formula I and methods of treatment comprising administering a therapeutically effective amount of the compound of formula I to a subject in need thereof.

Abstract: The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, wherein the variables Q and R are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.